Form 8-K - Current report:
SEC Accession No. 0001558370-23-002901
Filing Date
2023-03-06
Accepted
2023-03-06 16:05:21
Documents
54
Period of Report
2023-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imrx-20230306x8k.htm   iXBRL 8-K 40948
2 EX-99.1 imrx-20230306xex99d1.htm EX-99.1 238716
3 EX-99.2 imrx-20230306xex99d2.htm EX-99.2 75553
4 GRAPHIC imrx-20230306xex99d1002.jpg GRAPHIC 6512
5 GRAPHIC imrx-20230306xex99d2g001.jpg GRAPHIC 145832
6 GRAPHIC imrx-20230306xex99d2g002.jpg GRAPHIC 393857
7 GRAPHIC imrx-20230306xex99d2g003.jpg GRAPHIC 195411
8 GRAPHIC imrx-20230306xex99d2g004.jpg GRAPHIC 117578
9 GRAPHIC imrx-20230306xex99d2g005.jpg GRAPHIC 122996
10 GRAPHIC imrx-20230306xex99d2g006.jpg GRAPHIC 113279
11 GRAPHIC imrx-20230306xex99d2g007.jpg GRAPHIC 102597
12 GRAPHIC imrx-20230306xex99d2g008.jpg GRAPHIC 127385
13 GRAPHIC imrx-20230306xex99d2g009.jpg GRAPHIC 181225
14 GRAPHIC imrx-20230306xex99d2g010.jpg GRAPHIC 197660
15 GRAPHIC imrx-20230306xex99d2g011.jpg GRAPHIC 202325
16 GRAPHIC imrx-20230306xex99d2g012.jpg GRAPHIC 180714
17 GRAPHIC imrx-20230306xex99d2g013.jpg GRAPHIC 118100
18 GRAPHIC imrx-20230306xex99d2g014.jpg GRAPHIC 158759
19 GRAPHIC imrx-20230306xex99d2g015.jpg GRAPHIC 176011
20 GRAPHIC imrx-20230306xex99d2g016.jpg GRAPHIC 151520
21 GRAPHIC imrx-20230306xex99d2g017.jpg GRAPHIC 159449
22 GRAPHIC imrx-20230306xex99d2g018.jpg GRAPHIC 119250
23 GRAPHIC imrx-20230306xex99d2g019.jpg GRAPHIC 103099
24 GRAPHIC imrx-20230306xex99d2g020.jpg GRAPHIC 190129
25 GRAPHIC imrx-20230306xex99d2g021.jpg GRAPHIC 208668
26 GRAPHIC imrx-20230306xex99d2g022.jpg GRAPHIC 102354
27 GRAPHIC imrx-20230306xex99d2g023.jpg GRAPHIC 139081
28 GRAPHIC imrx-20230306xex99d2g024.jpg GRAPHIC 194533
29 GRAPHIC imrx-20230306xex99d2g025.jpg GRAPHIC 111212
30 GRAPHIC imrx-20230306xex99d2g026.jpg GRAPHIC 115711
31 GRAPHIC imrx-20230306xex99d2g027.jpg GRAPHIC 166321
32 GRAPHIC imrx-20230306xex99d2g028.jpg GRAPHIC 173243
33 GRAPHIC imrx-20230306xex99d2g029.jpg GRAPHIC 114465
34 GRAPHIC imrx-20230306xex99d2g030.jpg GRAPHIC 153253
35 GRAPHIC imrx-20230306xex99d2g031.jpg GRAPHIC 148444
36 GRAPHIC imrx-20230306xex99d2g032.jpg GRAPHIC 161242
37 GRAPHIC imrx-20230306xex99d2g033.jpg GRAPHIC 151156
38 GRAPHIC imrx-20230306xex99d2g034.jpg GRAPHIC 152887
39 GRAPHIC imrx-20230306xex99d2g035.jpg GRAPHIC 173311
40 GRAPHIC imrx-20230306xex99d2g036.jpg GRAPHIC 175192
41 GRAPHIC imrx-20230306xex99d2g037.jpg GRAPHIC 171303
42 GRAPHIC imrx-20230306xex99d2g038.jpg GRAPHIC 181451
43 GRAPHIC imrx-20230306xex99d2g039.jpg GRAPHIC 157025
  Complete submission text file 0001558370-23-002901.txt   9078657

Data Files

Seq Description Document Type Size
44 EX-101.SCH imrx-20230306.xsd EX-101.SCH 3157
45 EX-101.LAB imrx-20230306_lab.xml EX-101.LAB 16579
46 EX-101.PRE imrx-20230306_pre.xml EX-101.PRE 10461
48 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20230306x8k_htm.xml XML 4993
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 23708911
SIC: 2834 Pharmaceutical Preparations